A dynamic healthcare leader with extensive experience in medical affairs and late-stage clinical development, Dr. Schachner is widely recognized as a transformative change agent and highly respected collaborator with business and alliance partners. She has built global medical teams that have launched new therapies and won prestigious awards for their innovation and impact. Dr. Schachner joined Double Rainbow from MyoKardia, where she was SVP, Therapeutic Head of Clinical Science leading a new therapeutic area focused on diastolic dysfunction, myocardial inflammation, and ischemia. Prior to joining MyoKardia, Dr. Schachner was Chief Medical Officer Specialty Medicine at Allergan, where she led the transformation to a matrixed medical organization, and developed innovative and global approaches to education and clinical trials. Throughout her career, she has also held leadership roles as North America Medical Head for the Diabetes Cardiovascular (DCV) Business Unit at Sanofi, while serving simultaneously as U.S. Medical Chair, meeting with stakeholders on Capitol Hill to gather insights on patient and healthcare system needs. Earlier in her career, she held medical leadership positions at Bayer Diabetes Care, Pfizer, Inc., and Columbia University.